A study on the reprocessing and reusing of single-use devices
by Giuliana Miglierini Reprocessing and reusing are one of the key actions central to many new EU policies…
The current status of the transition to the MDR and IVDR regulations
by Giuliana Miglierini As the term to apply for the certification of medical devices and in vitro diagnostics…
EMA’s recommendations to prevent medicines shortages
By Giuliana Miglierini Continuity of medicinal product supply is still representing a key issue for European countries. The…
PIC/S new guidance documents for GDP inspectors
By Giuliana Miglierini Two new guidance documents for GDP inspectors have been issued by the Pharmaceutical Inspection Cooperation…
MDCG, a position paper on the capacity of notified bodies
by Giuliana Miglierini The lack of a suitable capacity of notified bodies (NBs) is one of the main…
EMA’s Industry stakeholders group (ISG)
by Giuliana Miglierini The Industrial Stakeholder Group (ISG) is a new initiative recently launched by the European Medicines…